Malaria Drugs Market Size, Share & Industry Analysis, By Drug (Artemisinin-based Therapies, Non-artemisinin Combination Therapies, Quinoline-based Drugs, Antifolate Antimalarials, 8-Aminoquinolines / Anti-relapse Drugs, Antibiotic Antimalarials), By Disease Type (Uncomplicated Malaria, Severe / Complicated Malaria), By Age Group (Pediatric, and Adults), By Type (Branded and Generics), By Route of Administration (Oral and Others), By Distribution Channel (Public Health Programs & Government Facilities, Hospital Pharmacies, Retail Pharmacies & Drug Stores), and Regional Forecast, 2026-2034

Last Updated: June 26, 2026 | Format: PDF | Report ID: FBI117791

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 5.74% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Drug, Disease Type, Age Group, Type, Route of Administration, Distribution Channel, and Region
By Drug	Artemisinin-based Therapies Non-artemisinin Combination Therapies Quinoline-based Drugs Antifolate Antimalarials 8-Aminoquinolines / Anti-relapse Drugs Antibiotic Antimalarials Others
By Disease Type	Uncomplicated Malaria Severe / Complicated Malaria Others
By Age Group	Pediatric Adults
By Type	Branded Generics
By Route of Administration	Oral Others
By Distribution Channel	Public Health Programs & Government Facilities Hospital Pharmacies Retail Pharmacies & Drug Stores Others
By Region	North America (By Drug, Disease Type, Age Group, Type, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Drug, Disease Type, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Drug, Disease Type, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug, Disease Type, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug, Disease Type, Age Group, Type, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa